---
id: "entity-khosla-ventures"
type: "entity"
entityType: "organization"
canonicalName: "Khosla Ventures"
aliases: []
source_timestamps: ["§ 4. Extend AMC research investments beyond early-stage science.", "¶18"]
tags: ["venture-capital", "partnerships"]
related: ["concept-amc-strategic-financing", "entity-cleveland-clinic"]
sources: ["tail2"]
sourceVaultSlug: "hbr-seg-tail2"
originDay: 2
articleStem: "hbr-tail-131-medical-drug-discovery"
sourceUrl: "https://hbr.org/2026/04/u-s-medical-centers-need-a-new-model-for-drug-discovery-and-development"
sourceTitle: "U.S. Medical Centers Need a New Model for Drug Discovery and Development"
---
# Khosla Ventures

A traditional **venture-capital fund** — known for health-tech and biotech investing — that partnered with [[entity-cleveland-clinic-d2]] to pair **venture funding with institutional health-system access** for incubating early-stage medical innovations. Canonically a **VC partner rather than an academic institution**, it embodies the co-investment half of [[concept-amc-strategic-financing]] and [[action-strategic-vc-partnerships]].